Nan Fung Group Holdings’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-160,570
Closed -$5.35M 41
2024
Q3
$5.35M Buy
160,570
+16,000
+11% +$551K 4.61% 6
2024
Q2
$3.91M Buy
144,570
+26,315
+22% +$519K 4.17% 9
2024
Q1
$2.55M Buy
+118,255
New +$2.58M 2.37% 13

Nan Fung Group Holdings's LBPH Position: Q4 2024 in Review

Nan Fung Group Holdings sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 160,570 shares — an estimated $5.35M sold.

Nan Fung Group Holdings first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $5.35M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • Nan Fung Group Holdings reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Nan Fung Group Holdings sold 160,570 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $5.35M.
  • Nan Fung Group Holdings first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
  • Nan Fung Group Holdings's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $5.35M in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Nan Fung Group Holdings's 13F filing for Q4 2024, filed 13 Feb 2025.